BioNexus Gene Lab Corp. (NASDAQ:BGLC) Sees Significant Increase in Short Interest

BioNexus Gene Lab Corp. (NASDAQ:BGLC) saw a large increase in short interest in December. As of December 31st, there was short interest totalling 354,000 shares, an increase of 79.6% from the December 15th total of 197,100 shares. Based on an average daily trading volume, of 3,780,000 shares, the short-interest ratio is currently 0.1 days. Currently, 3.0% of the shares of the stock are sold short.

BioNexus Gene Lab Stock Performance

BGLC stock opened at $0.38 on Friday. The business has a 50 day simple moving average of $0.30 and a 200-day simple moving average of $0.39. BioNexus Gene Lab has a 1 year low of $0.21 and a 1 year high of $3.39.

About BioNexus Gene Lab

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.